We are live on ! Find out more
IP

Intellectus Partners Portfolio holdings

AUM $578M
1-Year Est. Return 49.48%
This Fund
S&P 500
This Quarter Est. Return
+6.7%
1 Year Est. Return
+49.48%
3 Year Est. Return
+157.34%
5 Year Est. Return
+153.66%
10 Year Est. Return
–
AUM
$287M
AUM Growth
+$6.1M
Cap. Flow
-$504K
Cap. Flow %
-0.18%
Top 10 Hldgs %
21.21%
Holding
276
New
14
Increased
111
Reduced
100
Closed
13
Avg Time Held Equity + Options
11 quarters
Top 10 Avg Time Held Equity + Options
8.1 quarters
Top 20 Avg Time Held Equity + Options
10.4 quarters
Avg Time Held Equity only
11.1 quarters
Top 10 Avg Time Held Equity only
8.1 quarters
Top 20 Avg Time Held Equity only
10.4 quarters

Sector Composition

Rank Sector Weight
1 Miscellaneous 23.74%
2 Technology 17.89%
3 Healthcare 15.97%
4 Consumer Discretionary 9.94%
5 Industrials 8.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
AR icon
151
Antero Resources
AR
$11.5B
$570K 0.2%
+18,400
New +$636K
2022 Q4
0 quarters
C icon
152
Citigroup
C
$209B
$564K 0.2%
12,475
-1,350
-10% -$61.3K
2016 Q4
24 quarters
BKNG icon
153
Booking.com
BKNG
$118B
$562K 0.2%
6,975
+2,600
+59% +$197K
2022 Q3
1 quarter
MO icon
154
Altria Group
MO
$119B
$562K 0.2%
12,038
+242
+2% +$11K
2017 Q2
22 quarters
IOVA icon
155
Iovance Biotherapeutics
IOVA
$6.57B
$560K 0.2%
87,650
+41,673
+91% +$325K
2019 Q4
12 quarters
FLOT icon
156
iShares Floating Rate Bond ETF
FLOT
$11.3B
$557K 0.19%
11,064
-1,844
-14% -$92.6K
2022 Q2
2 quarters
SWKS icon
157
Skyworks Solutions
SWKS
$18B
$543K 0.19%
5,960
-2,308
-28% -$207K
2021 Q1
7 quarters
CFLT icon
158
DELISTED
Confluent
CFLT
$539K 0.19%
24,250
– –
2022 Q2
2 quarters
TMO icon
159
Thermo Fisher Scientific
TMO
$245B
$525K 0.18%
+953
New +$505K
2022 Q4
0 quarters
BIDU icon
160
Baidu
BIDU
$28.5B
$524K 0.18%
4,577
+370
+9% +$37.8K
2017 Q2
22 quarters
VVV icon
161
Valvoline
VVV
$3.85B
$520K 0.18%
15,916
– –
2020 Q4
8 quarters
NKE icon
162
Nike
NKE
$52.5B
$509K 0.18%
4,349
-22
-0.5% -$2.21K
2016 Q4
24 quarters
COIN icon
163
Coinbase
COIN
$48B
$509K 0.18%
14,375
+8,225
+134% +$433K
2022 Q2
2 quarters
CMCSA icon
164
Comcast
CMCSA
$74.1B
$509K 0.18%
14,547
+2,148
+17% +$71.1K
2016 Q4
24 quarters
ZTS icon
165
Zoetis
ZTS
$30.7B
$504K 0.18%
3,436
– –
2016 Q4
24 quarters
VUG icon
166
Vanguard Morningstar Growth ETF
VUG
$237B
$498K 0.17%
14,034
– –
2019 Q4
12 quarters
UL icon
167
Unilever
UL
$135B
$498K 0.17%
8,796
+304
+4% +$16.3K
2020 Q4
8 quarters
WDC icon
168
Western Digital
WDC
$143B
$498K 0.17%
20,877
+2,911
+16% +$76.8K
2021 Q2
6 quarters
INTC icon
169
Intel
INTC
$543B
$492K 0.17%
18,597
-2,405
-11% -$66.8K
2019 Q4
12 quarters
SIL icon
170
Global X Silver Miners ETF NEW
SIL
$4.26B
$491K 0.17%
17,400
– –
2022 Q1
3 quarters
SH icon
171
ProShares Short S&P500
SH
$973M
$467K 0.16%
7,288
+4,136
+131% +$265K
2019 Q1
15 quarters
AFMD icon
172
DELISTED
Affimed
AFMD
$454K 0.16%
36,615
+9,803
+37% +$172K
2021 Q2
6 quarters
MBB icon
173
iShares MBS ETF
MBB
$35.7B
$446K 0.16%
4,807
+2,375
+98% +$219K
2019 Q1
15 quarters
SNOW icon
174
Snowflake
SNOW
$126B
$433K 0.15%
3,020
+1,800
+148% +$275K
2022 Q3
1 quarter
RLAY icon
175
Relay Therapeutics
RLAY
$3.8B
$430K 0.15%
28,785
+2,800
+11% +$53.6K
2020 Q4
8 quarters

Similar funds

Intellectus Partners's Q4 2022 Portfolio in Review

As of Q4 2022, Intellectus Partners held 276 positions worth $287M, up 2.2% from $281M the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Intellectus Partners's Q4 2022 filing shows 14 new, 111 increased, 100 reduced and 13 closed positions. Its largest new stake was iShares Semiconductor ETF: 6,690 shares worth $776K. The largest sale was AbCellera Biologics, an estimated $2.58M.

By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 22% a quarter earlier, followed by Technology and Healthcare.

  • Intellectus Partners's largest Q4 2022 buy was iShares Semiconductor ETF: 6,690 shares worth $776K.
  • Intellectus Partners added most to Vanguard Morningstar Mid-Cap ETF in Q4 2022, an estimated $743K increase.
  • Intellectus Partners's biggest Q4 2022 reduction was AbCellera Biologics, cutting an estimated $2.58M.
  • Intellectus Partners fully exited General Dynamics in Q4 2022, selling an estimated $803K.
  • Intellectus Partners's ten largest holdings make up 21% of its $287M portfolio in Q4 2022.
  • Intellectus Partners opened 14 new positions and closed 13 in Q4 2022.
  • Intellectus Partners's portfolio value rose 2.2% quarter-over-quarter to $287M.

Based on Intellectus Partners's 13F filing for Q4 2022, filed 2 Feb 2023.